(MS04-1) A novel conditionally replicating adenovirus for nasopharyngeal carcinoma (NPC) gene therapy .
Chia, Marie^*,1, Li, Jian-Hua¹, Strathdee, Craig², Huang, Dolly³, Klamut, Henry¹, Liu, Fei-Fei¹, ¹ Departments of Medical Biophysics and Radiation Oncology, Toronto, Ontario² Immunex Corporation, Seattle, Washington³ Chinese University of Hong Kong
FULL ABSTRACT

(MS04-2) Low-Dose Fractionated Radiation Potentiates the Effects of Paclitaxel in Wild-Type and Mutant p53 Head and Neck Tumor Cell Lines.
Arnold, Suzanne², Valentino, Joseph², Chendil, Damodaran¹, Das, Anindita¹, Mohiuddin, Mohammed¹, Ahmed, Mansoor¹, Dey, Swatee^*,1, ² Department of Clinical Sciences, Lexington, KY¹ Department of Radiation Medicine, Lexington, KY
FULL ABSTRACT

(MS04-3) Effect of Motexafin Gadolinium on the morphology, growth, viability, and radiation response of EMT6 cells in vitro.
Donnelly, Erling^*,1, Tang, Li-Qun¹, Rockwell, Sara¹, ¹ Department of Therapeutic Radiology, New Haven, CT
FULL ABSTRACT

(MS04-4) Late health effects of nasopharyngeal radium irradiation: cancer incidence.
Ronckers, Cécile^*,1,2, Land, Charles², Verduijn, Pieter¹, Hayes, Richard², Stovall, Marilyn³, van Leeuwen, Flora⁴, ¹ Reinaert Kliniek, Maastricht, the Netherlands² National Cancer Institute, Rockville, MD³ MD Anderson Cancer Center, Houston, TX⁴ The Netherlands Cancer Institute, Amsterdam, the Netherlands
FULL ABSTRACT

(MS04-5) Dose-volume-region effects in partial irradiation of rat lung.
Jiresova, Alena^*,1, Wiegman, Erwin¹, Kampinga, Harm¹, Coppes, Rob¹, ¹ Department of Radiation and Stress Cell Biology, Faculty of Medical Sciences, University of Groningen, Groningen, The Netherlands
FULL ABSTRACT

(MS04-6) Efficacy of ionizing radiation combined with adenoviral-p16 gene therapy in nasopharyngeal carcinoma.
Lee, Andrew Wing Cheong^*,1, Li, Jian-Hua¹, Liu, Ta-Jen³, Liu, Fei-Fei^1,2, ¹ Department of Medical Biophysics, Toronto, Ontario³ MD Anderson Cancer Center, Houston, Texas² Department of Radiation Oncology, Toronto, Ontario
FULL ABSTRACT

(MS04-7) Y-90 labeled integrin antagonist (IA-NP-Y90): a novel anti-angiogenesis therapy using nanoparticles.
Li, Lingyun^*,1, Ning, Shoucheng¹, Danthi, Narasimhan³, Choi, Steven³, Bednarski, Mark^2,3, Knox, Susan¹, ¹ Department of Radiation Oncology, Stanford, CA³ Targesome, Inc., Palo Alto, CA² Department of Radiology, Stanford, CA
FULL ABSTRACT

(MS04-8) Radiation affects antigen presentation by dendritic cells.
Liao, Yu-Pei^*,1, McBride, William¹, ¹ Department of Radiation Oncology, Los Angeles, CA
FULL ABSTRACT